{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:14:48Z","timestamp":1790144088777,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jprot.2012.04.017","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T18:37:04Z","timestamp":1335033424000},"page":"3617-3629","source":"Crossref","is-referenced-by-count":75,"title":["Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease"],"prefix":"10.1016","volume":"75","author":[{"given":"Ming-Hui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang-Bin","family":"Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyh-Jong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Wen","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chang","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2012.04.017_bb0005","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jnen\/60.10.923","article-title":"Alzheimer disease therapeutics","volume":"60","author":"Irizarry","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","article-title":"Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer's disease","volume":"19","author":"The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and National Institute on Aging Working Group","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jprot.2012.04.017_bb0020","first-page":"9","article-title":"Potential peripheral biomarkers for the diagnosis of Alzheimer's disease","author":"Patel","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"Shaw","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2010.08.018","article-title":"Olfactory deficit detected by fMRI in early Alzheimer's disease","volume":"1357","author":"Wang","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.jprot.2012.04.017_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/bmm.09.84","article-title":"Blood-based biomarkers of Alzheimer's disease: challenging but feasible","volume":"4","author":"Thambisetty","year":"2010","journal-title":"Biomark Med"},{"key":"10.1016\/j.jprot.2012.04.017_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-110731","article-title":"Salivary tau species are potential biomarkers of Alzheimer disease","volume":"27","author":"Shi","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0045","first-page":"1","article-title":"Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study","volume":"29","author":"Zabel","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0050","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3233\/JAD-2010-1303","article-title":"The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease","volume":"19","author":"Mueller","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000330750","article-title":"A blood-based algorithm for the detection of Alzheimer's disease","volume":"32","author":"O'Bryant","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jprot.2012.04.017_bb0060","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer's disease","volume":"129","author":"Hye","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jprot.2012.04.017_bb0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-010-0680-3","article-title":"CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy","volume":"119","author":"Zilka","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exger.2009.09.005","article-title":"Blood-based biomarkers of microvascular pathology in Alzheimer's disease","volume":"45","author":"Ewers","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00726-004-0141-1","article-title":"Depletion of the high-abundance plasma proteins","volume":"27","author":"Fountoulakis","year":"2004","journal-title":"Amino Acids"},{"key":"10.1016\/j.jprot.2012.04.017_bb0080","doi-asserted-by":"crossref","first-page":"e23112","DOI":"10.1371\/journal.pone.0023112","article-title":"Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera","volume":"6","author":"Nagele","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jprot.2012.04.017_bb0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00216-007-1263-6","article-title":"Identification of human hepatocellular carcinoma-related proteins by proteomic approaches","volume":"388","author":"Yang","year":"2007","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jprot.2012.04.017_bb0090","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/pmic.200401041","article-title":"Proteomic analysis of human pleural effusion","volume":"5","author":"Tyan","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2012.04.017_bb0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0197-4580(01)00328-1","article-title":"Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid","volume":"23","author":"Teunissen","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jprot.2012.04.017_bb0100","series-title":"Dialogues in clinical neuroscience","author":"Macher","year":"2000"},{"key":"10.1016\/j.jprot.2012.04.017_bb0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2008.10.003","article-title":"Biomarkers of Alzheimer's disease","volume":"35","author":"Craig-Schapiro","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/prca.200600684","article-title":"Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease","volume":"1","author":"Liao","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2012.04.017_bb0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1755-5949.2009.00104.x","article-title":"Biological marker candidates of Alzheimer's disease in blood, plasma, and serum","volume":"15","author":"Schneider","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jprot.2012.04.017_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nbd.2008.09.004","article-title":"Biomarker discovery in neurodegenerative diseases: a proteomic approach","volume":"35","author":"Shi","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0125","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s00415-008-0006-8","article-title":"Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease","volume":"255","author":"Thambisetty","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000046325","article-title":"Alpha-1-antitrypsin deficiency and nephropathy","volume":"90","author":"Montanelli","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.jprot.2012.04.017_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.03.012","article-title":"AAT as a diagnostic tool","volume":"352","author":"Lisowska-Myjak","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jprot.2012.04.017_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001756-199202000-00020","article-title":"Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease","volume":"3","author":"Gollin","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.jprot.2012.04.017_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2006.06.009","article-title":"Characterization of \u03b11-antitrypsin as a heme oxygenase-1 suppressor on Alzheimer plasma","volume":"20","author":"Maes","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/JAD-2005-8302","article-title":"Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1 + AbetaPP mouse model of Alzheimer's disease","volume":"8","author":"Soreghan","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0155","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2005.09.021","article-title":"Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jprot.2012.04.017_bb0160","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI119358","article-title":"Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV","volume":"99","author":"Cohen","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jprot.2012.04.017_bb0165","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.273.5277.966","article-title":"Protection against atherogenesis in mice mediated by human apolipoprotein A-IV","volume":"273","author":"Duverger","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jprot.2012.04.017_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(97)00500-4","article-title":"Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease","volume":"230","author":"Cs\u00e1sz\u00e1ra","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jprot.2012.04.017_bb0175","first-page":"H1836","article-title":"Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation","volume":"274","author":"Qin","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0180","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00702-005-0424-z","article-title":"Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia","volume":"113","author":"Wang","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jprot.2012.04.017_bb0185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/prca.200600999","article-title":"Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease","volume":"1","author":"Hu","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2012.04.017_bb0190","first-page":"886","article-title":"Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease","volume":"143","author":"Kalaria","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2007.12.1053","article-title":"Protein biomarker identification in the CSF of patients with CNS lymphoma","volume":"26","author":"Roy","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jprot.2012.04.017_bb0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0169-328X(91)90045-Y","article-title":"Production of thrombin and antithrombin III by brain and astroglial cell cultures","volume":"11","author":"Deschepper","year":"1991","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jprot.2012.04.017_bb0205","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.72.7.3777-3782.2004","article-title":"ITIH4 (Inter-Alpha-Trypsin Inhibitor Heavy Chain 4) is a new acute-phase protein isolated from cattle during experimental infection","volume":"72","author":"Pi\u00f1eiro","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jprot.2012.04.017_bb0210","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jprot.2012.04.017_bb0215","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1021\/pr060225u","article-title":"Peptidomics for cancer diagnosis: present and future","volume":"5","author":"Diamandis","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2012.04.017_bb0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/bbrc.1999.1349","article-title":"ITIH4 serum concentration increases during acute-phase processes in human patients and up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells","volume":"263","author":"Pi\u00f1eiro","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jprot.2012.04.017_bb0225","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1373\/clinchem.2004.036871","article-title":"Mass spectrometric analysis of protein markers for ovarian cancer","volume":"50","author":"Wang","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2012.04.017_bb0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresrev.2009.05.003","article-title":"Plasma biomarkers for mild cognitive impairment and Alzheimer's disease","volume":"61","author":"Songa","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.jprot.2012.04.017_bb0235","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1073\/pnas.1331636100","article-title":"Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity","volume":"100","author":"Wilkemeyer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jprot.2012.04.017_bb0240","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3233\/JAD-2010-1335","article-title":"The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules","volume":"19","author":"Yenjerla","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2012.04.017_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-0115(00)00198-1","article-title":"A Novel peptide prevents death in enriched neuronal cultures","volume":"96","author":"Zemlyak","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.jprot.2012.04.017_bb0250","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of alzheimer's disease","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jprot.2012.04.017_bb0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1567205053585873","article-title":"The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury","volume":"2","author":"Gozes","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.jprot.2012.04.017_bb0260","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.107.129551","article-title":"Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model","volume":"323","author":"Vulih-Shultzman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jprot.2012.04.017_bb0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12031-009-9300-x","article-title":"Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein\/presenilin 1 mouse model of Alzheimer's disease","volume":"41","author":"Fernandez-Montesinos","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jprot.2012.04.017_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.32725\/jab.2005.008","article-title":"Neuroprotective peptides as drug candidates against Alzheimer's disease","volume":"3","author":"Patocka","year":"2005","journal-title":"J Appl Biomed"},{"key":"10.1016\/j.jprot.2012.04.017_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-9-S3-S3","article-title":"NAP and D-SAL: neuroprotection against the \u03b2 amyloid peptide (1\u201342)","volume":"9","author":"Gozes","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.jprot.2012.04.017_bb0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/bib\/3.3.275","article-title":"High-quality protein knowledge resource: SWISS-PROT and TrEMBL","volume":"3","author":"O'Donovan","year":"2002","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jprot.2012.04.017_bb0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1073\/pnas.97.1.179","article-title":"Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors","volume":"7","author":"Pandey","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jprot.2012.04.017_bb0290","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: the proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391912002230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391912002230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T05:17:20Z","timestamp":1687411040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391912002230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1874391912002230"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2012.04.017","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}